Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance) Meeting Abstract


Authors: George, D. J.; Halabi, S.; Starr, M. D.; Hurwitz, H.; Brady, J. C.; Barak, I.; Morris, M. J.; Rini, B. I.; Small, E. J.; Kim, W.; Taplin, M. E.; Nixon, A. B.
Abstract Title: Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 242s
Language: English
ACCESSION: WOS:000411931702022
DOI: 10.1200/JCO.2017.35.15_suppl.4522
PROVIDER: wos
Notes: Meeting Abstract: 4522 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris